KYCCF announced a cash dividend of 275.00$ with an ex-date of Mar. 18, 2026 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

KYCCF announced a cash dividend of 275.00$ with an ex-date of Mar. 18, 2026 ...

There’s been the usual flurry of announcements in the build-up to JP Morgan’s Annual Healthcare Conference, where pharma leaders will pitch their pipeline ideas to investors. While some companies will ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...